Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Alpha₁A adrenergic receptor (α1A adrenoreceptor), encoded by the ADRA1A gene, is a subtype of the alpha-1 adrenergic receptors and belongs to the G protein-coupled receptor (GPCR) superfamily. Activation leads to stimulation of phospholipase C (PLC), generating second messengers inositol trisphosphate (IP3) and diacylglycerol (DAG), resulting in increased intracellular calcium levels. It is highly expressed in smooth muscle cells throughout blood vessels and other tissues, mediating vasoconstriction. It also plays roles in neurotransmission within the CNS and participates in the development/growth/functioning of heart tissue. Alpha₁-adrenoceptors are targets for drugs treating hypertension or benign prostatic hyperplasia.
Agonist or antagonist binding to the Alpha₁A adrenergic receptor modulating downstream signaling via Gq/11 proteins and phospholipase C activation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha₁A adrenergic receptor.